Additionally, experiments in a mouse model for diabetes-accelerated atherosclerosis showed that inhibition of HSP90 was found to reduce both inflammation and oxidative stress in addition to limiting vascular and renal damage [214]. This evidence concerns the gene HSP90AB1 and atherosclerosis.